Stock Taper

REGENERON PHARMACEUTICALS, INC.

Latest 13F filing data - Q2 2026

Holdings

(Top positions)
STOCKTICKERSHARES HELD VALUE
Intellia Therapeutics, Inc.NTLA3.7M$62.65M